Exousia Bio (LMMY) EBITDA Margin (2023 - 2024)
Exousia Bio (LMMY) posted EBITDA Margin of -648.48% for FY2025 (year ended May 31, 2025), down 548.11 percentage points from -100.37% in FY2024.
Powered by 
Analysis
Exousia Bio (LMMY) EBITDA Margin (2023 - 2024) Analysis & Trends
- Business Quant data shows LMMY's EBITDA Margin at -100.37% in FY2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Bryn | 945.00 Bn | 945.00 Bn | - | - |
| 2 | Veeva Systems | 45.09 Bn | 17.34 Bn | 695.95 Mn | 31.34% |
| 3 | Samsara | 22.22 Bn | 18.99 Bn | 392.58 Mn | 2.61% |
| 4 | Toast | 17.58 Bn | 10.25 Bn | 516.00 Mn | 9.85% |
| 5 | Ptc | 15.23 Bn | 14.05 Bn | 490.47 Mn | 31.78% |
| 6 | Trimble | 13.37 Bn | 12.44 Bn | 674.90 Mn | 18.84% |
| 7 | Duolingo | 13.34 Bn | 8.51 Bn | 216.74 Mn | 12.80% |
| 8 | Manhattan Associates | 11.67 Bn | 10.66 Bn | 168.33 Mn | 22.79% |
| 9 | Costar | 10.92 Bn | 4.88 Bn | 728.00 Mn | 20.65% |
| 10 | Exousia Bio | 335,295.33 | 335,295.33 | -62,108.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2024 | -17.81% |
| May 31, 2024 | -53.71% |
| Feb 29, 2024 | -129.57% |
| Nov 30, 2023 | -97.39% |
API Access
Exousia Bio EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LMMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "LMMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LMMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();